Fresenius Medical Care AG & Co. KGAA (ETR:FME) received a €85.00 ($100.00) price objective from analysts at HSBC Holdings PLC in a note issued to investors on Wednesday. The brokerage currently has a “neutral” rating on the stock. HSBC Holdings PLC’s price target indicates a potential upside of 3.03% from the stock’s current price.

A number of other analysts have also weighed in on FME. Deutsche Bank AG set a €84.00 ($98.82) target price on Fresenius Medical Care AG & Co. KGAA and gave the stock a “neutral” rating in a research note on Tuesday, August 8th. Goldman Sachs Group Inc set a €97.00 ($114.12) target price on Fresenius Medical Care AG & Co. KGAA and gave the stock a “buy” rating in a research note on Tuesday, August 8th. J P Morgan Chase & Co set a €95.10 ($111.88) target price on Fresenius Medical Care AG & Co. KGAA and gave the stock a “buy” rating in a research note on Tuesday, August 8th. Commerzbank Ag set a €88.00 ($103.53) target price on Fresenius Medical Care AG & Co. KGAA and gave the stock a “neutral” rating in a research note on Monday, August 7th. Finally, Kepler Capital Markets set a €95.00 ($111.76) target price on Fresenius Medical Care AG & Co. KGAA and gave the stock a “buy” rating in a research note on Wednesday, August 2nd. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of €89.05 ($104.77).

Shares of Fresenius Medical Care AG & Co. KGAA (ETR:FME) opened at €82.50 ($97.06) on Wednesday. Fresenius Medical Care AG & Co. KGAA has a 52-week low of €71.49 ($84.11) and a 52-week high of €89.22 ($104.96).

TRADEMARK VIOLATION WARNING: This news story was first published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.watchlistnews.com/fresenius-medical-care-ag-85-00-by-hsbc-holdings-plc/1722839.html.

About Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGAA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGAA and related companies with Analyst Ratings Network's FREE daily email newsletter.